TAFASITAMAB

UNII:	QQA9MLH692
Formula:
Preferred Substance Name:	TAFASITAMAB

1422527-84-1
HUMANIZED FC ENGINEERED MONOCLONAL ANTIBODY AGAINST CD19
IMMUNOGLOBULIN, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MOR00208 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MOR00208 .KAPPA.-CHAIN, DIMER
MONJUVI
MOR00208
MOR-00208
MOR-208
TAFASITAMAB [INN]
TAFASITAMAB [MI]
TAFASITAMAB [USAN]
TAFASITAMAB [WHO-DD]
TAFASITAMAB CXIX [WHO-DD]
TAFASITAMAB-CXIX
XMAB5574
XMAB-5574

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TAFASITAMAB

Synonyms and Mappings

Resources